{"Name":"Achaogen","perma":"achaogen","BasicInfo":{"funded":"2004-01-01","isClosed":false,"closed":null,"short":"Achaogen, a biopharmaceutical company, discovers and develops broad-spectrum antibiotics to treat multi-drug resistant bacterial infections."},"FundingRounds":[{"funding_type":"post_ipo_equity","series":null,"announcedDate":"2016-06-14","moneyRaised":25449987},{"funding_type":"venture","series":"D","announcedDate":"2013-03-22","moneyRaised":18905707},{"funding_type":"venture","series":"c","announcedDate":"2010-04-07","moneyRaised":56000000},{"funding_type":"venture","series":"b","announcedDate":"2006-10-10","moneyRaised":26000000},{"funding_type":"venture","series":"A","announcedDate":"2004-08-01","moneyRaised":15700000}],"Acquisitions":[],"AcquiredBy":null,"IPO":{"exchange":"NASDAQ","symbol":"AKAO","shares":6000000,"date":"2014-03-21","openPrice":12,"moneyRaised":72000000,"valuation":200400000},"Investments":[],"Products":[],"CurrentTeam":[{"title":"Vice President, Regulatory Affairs","started":"2012-09-01","ended":null,"firstName":"Christine","lastName":"Murray"},{"title":"Chief Medical Officer, Chief Executive Officer, Board of Directors","started":"2011-01-01","ended":null,"firstName":"Kenneth","lastName":"Hillan"},{"title":"SVP and VP, Development Operations and Portfolio Management","started":"2011-01-01","ended":null,"firstName":"Becki","lastName":"Filice"},{"title":"VP Finance & Corporate Development","started":"2012-01-01","ended":null,"firstName":"Dennis","lastName":"Hom"}],"PastTeam":[{"title":"Founder, CSO & CEO","started":"2004-05-01","ended":"2011-10-01","firstName":"Kevin","lastName":"Judice"},{"title":"Co-Founder","started":null,"ended":null,"firstName":"Nathaniel","lastName":"David"}]}
